Contact
Please use this form to send email to PR contact of this press release:
ProMetic's PBI-4050 Granted Orphan Drug Designation for the Treatment of Idiopathic Pulmonary Fibrosis in Europe
TO:
Please use this form to send email to PR contact of this press release:
ProMetic's PBI-4050 Granted Orphan Drug Designation for the Treatment of Idiopathic Pulmonary Fibrosis in Europe
TO: